top of page

New Additions

New Additions

Remarkable results have been obtained using psilocybin as an agent to aid with smoking cessation. Results are significantly better than the current standard of care. Scientists and doctors are beginning to take an interest, thought the mechanisms of benefit remain somewhat obscure.

This article gives context and points out that there is a societal set point that helps us restrain unwanted behaviors such as smoking, drinking while driving, and what is now current, opiate related overdoses.

The women’s health movement was nourished by the writings of a single woman. Good things can happen when medicine listens to the wisdom of the public.

Before schizophrenia becomes a major impairment in one late teens and early adulthood there are subtle signs that the disorder is developing. Because psychotic events are destructive to the brain, i.e. schizophrenia is neurodegenerative, early identification and treatment can be life changing.

Psychiatric Rx without Drugs

Psychiatric Rx

Human to AI interactions are quite common.  Above is a link to an excellent podcast with a sophisticated discussion on the nuances of such relationships.  We too have been thinking about AI in mental health and have a blog post considering the potential of a Chat Bot serving as therapist.

Stanford Accelerated Intelligent Neuromodulation Therapy is an enhanced form of TMS, a non pharmacologic therapy. The latter is part of a trend in modern psychiatry where treatments are beginning to take advantage of an awareness of the importance of brain circuits and connectivity rather than simply neurotransmitters and brain regions. TMS offers promise for many conditions, depression, anxiety, even substance abuse.

Psychedelics and Novel Treatments

NovelRx

Ketamine is a great a great tool to have in the toolbox of options we have to help patients with depression and other serious conditions. Its’ misuse however can be dangerous. Beware of for profit enterprises that can place their bottom line above the welfare of patients.

A Psychedelic Co. advances its drug toward FDA approval

© 2021 by Wellness First Psychiatric Associates, PLLC. 

bottom of page